NCT05982366

Brief Summary

The distal transradial approach (dTRA) via the anatomical snuffbox is hypothesized to be more beneficial than the conventional transradial access (cTRA) in patients undergoing coronary procedures. This prospective single-center randomized trial was designed to investigate the safety, efficacy, and various ultrasound parameters of dTRA.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

June 21, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 8, 2023

Completed
Last Updated

August 8, 2023

Status Verified

August 1, 2023

Enrollment Period

4 months

First QC Date

June 21, 2023

Last Update Submit

August 1, 2023

Conditions

Keywords

radial arterydistal transradial approachaccess complicationanatomical snuffbox

Outcome Measures

Primary Outcomes (1)

  • The primary composite endpoint consisted of rate of access crossover, rate of major adverse cardiovascular events (MACE) and rate of access-related vascular complications.

    Access crossover from unsuccessful random arterial access (if the initial access point fails) to another one. Access-related complications after the procedure measured with Doppler Ultrasound (included radial artery occlusion, significant hematoma (EASY classification grade III-V), arteriovenous fistula, pseudoaneurysm, perforation and spasm). MACE definied as myocardial infarction, stroke, urgent revascularization, all-cause death.

    up to 24 hours

Secondary Outcomes (4)

  • efficacy endpoint: rate of access crossover

    during the procedure index

  • safety endpoint: patients' discomfort evaluated during access performance

    during the procedure

  • efficacy endpoint: duration of access performance

    during the procedure index

  • safety endpoint: access-site vascular complications

    after 24 hours post procedure

Other Outcomes (3)

  • Access-time

    during procedure

  • radial artery size

    before the procedure, 24 hours and 60 days after the procedure

  • radial artery velocity

    before the procedure, 24 hours and 60 days after the procedure

Study Arms (2)

Distal transradial approach

EXPERIMENTAL

Distal transradial approach as the default strategy

Other: distal radial artery acess side

Conventional transradial approach

ACTIVE COMPARATOR

Conventional transradial approach as the default strategy

Other: conventional radial artery acess side

Interventions

coronary procedure (coronary angiography and/or coronary angioplasty) by the distal radial artery in the anatomical snuffbox area

Also known as: dTRA
Distal transradial approach

coronary procedure (coronary angiography and/or coronary angioplasty) by the forearm radial artery in the anatomical snuffbox area

Also known as: cTRA
Conventional transradial approach

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients referred for CAG and/or PCI

You may not qualify if:

  • ST-elevation myocardial infarction
  • sudden cardiac arrest
  • hemody-namic instability
  • chronic kidney disease (stages 4-5)
  • forearm artery occlusion
  • previous unsuccessful ipsilateral TRA
  • unfavorable RA diameter
  • ultrasound unavailability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Szpital Specjalistyczny

Chojnice, Pomeranian, 89-600, Poland

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Łukasz Koziński, MD

    Indywidualna Praltyka Lekarska Lekarz Łukasz Koziński

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Prospective, single-center, randomized trial
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator Łukasz Koziński, Indywidualna Praktyka Lekarska Lekarz Łukasz Koziński

Study Record Dates

First Submitted

June 21, 2023

First Posted

August 8, 2023

Study Start

November 1, 2022

Primary Completion

February 28, 2023

Study Completion

May 31, 2023

Last Updated

August 8, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations